Introduction
Spondyloarthritis (SpA) encompasses a group of inflammatory rheumatic diseases that primarily affect the joints, especially the spine. These disorders include well-known conditions like ankylosing spondylitis (AS), psoriatic arthritis (PsA), reactive arthritis (ReA), and those associated with inflammatory bowel diseases (IBD). However, there is a subset that often remains in the shadows, carrying its unique set of challenges, late-onset spondyloarthritis. This article will shed light on late-onset spondyloarthritis.
What Are the Features of Late-Onset Spondyloarthritis?
Late-onset spondyloarthritis is a distinct subset recently gaining increasing attention in the medical community. The distinctive feature of this illness is the later development of SpA symptoms, usually after the age of 50. Although spondyloarthritis disorders typically show symptoms in younger people, the late-onset version exhibits distinct clinical characteristics and diagnostic complications.
Usually, AS appears in people when they are younger, but it raises some intriguing concerns when it happens later in life. The main symptoms of ankylosing spondylitis include inflammation in the sacroiliac joints and spine, which can lead to spinal fusion and persistent pain and stiffness. What distinguishes late-onset AS are these essential characteristics:
-
Age of Onset: It is unusual for symptoms of AS to emerge after the age of 50. This age-related aspect differentiates late-onset AS from the typical onset in younger individuals.
-
Clinical Expression: Compared to early-onset AS, late-onset AS shows observable variations in its clinical expression. Surprisingly, studies have revealed that the age at which symptoms first appear has no discernible impact on disease activity, radiographic progression, the requirement for non-hip surgical treatments, or the frequency of extraarticular indications. This indicates that the overall severity and development of the disease remain largely stable, independent of the onset of symptoms.
-
Hip Involvement: The higher incidence of hip involvement in patients with early-onset AS is one of the most important differences. These symptoms are less common in persons with late-onset AS. This suggests that the hip plays a different function in late-onset AS, which may affect management and treatment.
-
Radiological Progression: One of the main characteristics of AS is radiological spinal progression, including vertebrae fusing. It has been noted that patients with hip involvement typically had more substantial spinal progression in both late-onset and early-onset cases. This implies that several joints interact intricately along the course of the disease.
-
Shoulder Involvement: Interestingly, shoulder involvement is more common in patients with late-onset AS, particularly in those with an onset between 35 and 45 years of age. This distinction draws attention to the variety of ways that the disease can present itself in relation to various age groups.
What Are the Diagnostic Challenges Associated With Late-Onset Spondyloarthritis?
Diagnosing late-onset spondyloarthritis (LOSA) can be particularly challenging due to several factors that differentiate it from typical spondyloarthritis (SpA) and the age-related comorbidities that can complicate the diagnostic process.
- Firstly, delayed diagnosis is one of the major diagnostic problems. LOSA is often misinterpreted as age-related musculoskeletal disorders such as fibromyalgia or degenerative joint disease. The patient may have prolonged suffering due to this misidentification, which can cause a significant delay in receiving the proper diagnosis and treatment.
- Second, LOSA frequently manifests as unusual symptoms, making diagnosis more challenging. While chronic back pain and stiffness are common in older people, they are more likely to attribute these symptoms to aging naturally than to an inflammatory disease. Consequently, there could be a delay in diagnosis when medical professionals fail to immediately recognize LOSA as a possible diagnosis.
- Moreover, disparities in imaging can make diagnosis more difficult. Even while MRIs and X-rays are useful diagnostic tools for SpA, these results might be weaker in older people, making it difficult to reach a firm diagnosis solely based on imaging.
- Lastly, coexisting age-related conditions frequently accompany LOSA, which can overshadow its symptoms. Differentiating between LOSA and other illnesses can be challenging for healthcare practitioners, particularly in age-related comorbidities such as osteoporosis or osteoarthritis. This overlap in symptomatology may cause misunderstanding in the diagnosis.
What Are the Diagnostic Criteria for Late-Onset Spondyloarthritis?
The primary focus of developing diagnostic criteria for young adult-onset SpA is the Assessment of SpondyloArthritis International Society (ASAS) and other related criteria. As a result, it is possible that LOSA does not fully meet these requirements. In order to diagnose a patient, healthcare professionals frequently have to rely on their clinical judgment and experience. A few of the diagnostic standards applied in LOSA are as follows:
-
Prolonged back pain and stiffness that lasts at least three months and gets better with activity but gets worse with rest.
-
The characteristics of inflammatory back pain include morning stiffness and movement relief.
-
Radiological evidence, such as sacroiliitis or other joint damage, on imaging.
-
Laboratory results point to inflammation, such as increased ESR (erythrocyte sedimentation rate) or CRP (cysteine-reactive protein).
What Are the Management Strategies for Late-Onset Spondyloarthritis?
Following diagnosis, the goals of LOSA management are to minimize discomfort, enhance function, reduce inflammation, and avoid long-term structural damage. Among the possible therapeutic approaches are:
1. Medications:
-
Nonsteroidal Anti-inflammatory Drugs (NSAIDs): NSAIDs are frequently the primary choice for treating LOSA patients to lessen pain and inflammation.
-
Disease-Modifying Antirheumatic Drugs (DMARDs): If a patient has peripheral joint involvement, DMARDs may be helpful for them.
-
Biologics: To treat inflammation in LOSA patients who do not respond well to NSAIDs or DMARDs, physicians may prescribe biologics like tumor necrosis factor (TNF) inhibitors.
-
Pain Management: Physical and cognitive-behavioral therapy are two pain management strategies that can enhance general well-being in people with chronic pain.
2. Lifestyle Modifications:
-
Weight Management: By keeping a healthy weight, one can lessen the strain on the joints and spine, which will help affected individuals feel better.
-
Quitting Smoking: Research has shown that smoking is linked to worse results from SpA. Giving up smoking can have a beneficial effect on managing LOSA.
-
Sufficient Sleep: Maintaining proper sleep hygiene can aid in managing LOSA-related pain and stiffness.
3. Patient Education:
-
Effective therapy depends on educating patients about LOSA, how to manage it, and how important it is to take their medications as prescribed.
-
Promoting self-management skills can enhance general well-being. Examples of these skills are stress management and early identification of flare-up indicators.
4. Regular Follow-Up:
- Regular follow-up visits with medical professionals are necessary to track the disease's advancement and modify the treatment strategy.
Conclusion
In summary, late-onset spondyloarthritis (LOSA) is a unique subtype of spondyloarthritis that poses particular difficulties for diagnosis and treatment. It frequently imitates age-related musculoskeletal disorders, which causes underdiagnosis and a delay in diagnosis. The diagnostic process is more difficult in older adults due to their unusual symptoms and overlapping comorbidities. However, a prompt and precise diagnosis is necessary to start the right treatment and enhance the quality of life for LOSA patients. When treating elderly patients with persistent back pain, stiffness, and other associated symptoms, healthcare professionals should look for signs of LOSA and treat it as a possible diagnosis. By tackling these issues, one can improve the care and results for those impacted by LOSA.
